G2G joins 4,000 others at MHSRS 2022. After the two-year hiatus due to COVID-19, the turnout is almost twice as high as 2019. The exhibit hall booths sold out and less than 50% of abstract submissions were selected to present posters this year. The attendees range from military researchers, program managers, Defense Health Agency (DHA) leadership and clinicians to startup and growing bioscience companies to institutions and pioneering researchers.
The first day entails DHA leadership sharing insights on priorities, congressional directives such as the consolidation under DHA, and the path forward in military medical research and care. Stay tuned for G2G’s report post MHSRS! We will post it here.